Cargando…

Autophagy, cell death, and cancer

Autophagy is an evolutionarily conserved intracellular catabolic process that is used by all cells to degrade dysfunctional or unnecessary cytoplasmic components through delivery to the lysosome. Increasing evidence reveals that autophagic dysfunction is associated with human diseases, such as cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Lin, Baehrecke, Eric H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905302/
https://www.ncbi.nlm.nih.gov/pubmed/27308466
http://dx.doi.org/10.4161/23723556.2014.985913
_version_ 1782437243479130112
author Lin, Lin
Baehrecke, Eric H
author_facet Lin, Lin
Baehrecke, Eric H
author_sort Lin, Lin
collection PubMed
description Autophagy is an evolutionarily conserved intracellular catabolic process that is used by all cells to degrade dysfunctional or unnecessary cytoplasmic components through delivery to the lysosome. Increasing evidence reveals that autophagic dysfunction is associated with human diseases, such as cancer. Paradoxically, although autophagy is well recognized as a cell survival process that promotes tumor development, it can also participate in a caspase-independent form of programmed cell death. Induction of autophagic cell death by some anticancer agents highlights the potential of this process as a cancer treatment modality. Here, we review our current understanding of the molecular mechanism of autophagy and the potential roles of autophagy in cell death, cancer development, and cancer treatment.
format Online
Article
Text
id pubmed-4905302
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-49053022016-06-15 Autophagy, cell death, and cancer Lin, Lin Baehrecke, Eric H Mol Cell Oncol Review Autophagy is an evolutionarily conserved intracellular catabolic process that is used by all cells to degrade dysfunctional or unnecessary cytoplasmic components through delivery to the lysosome. Increasing evidence reveals that autophagic dysfunction is associated with human diseases, such as cancer. Paradoxically, although autophagy is well recognized as a cell survival process that promotes tumor development, it can also participate in a caspase-independent form of programmed cell death. Induction of autophagic cell death by some anticancer agents highlights the potential of this process as a cancer treatment modality. Here, we review our current understanding of the molecular mechanism of autophagy and the potential roles of autophagy in cell death, cancer development, and cancer treatment. Taylor & Francis 2015-01-26 /pmc/articles/PMC4905302/ /pubmed/27308466 http://dx.doi.org/10.4161/23723556.2014.985913 Text en © 2015 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Review
Lin, Lin
Baehrecke, Eric H
Autophagy, cell death, and cancer
title Autophagy, cell death, and cancer
title_full Autophagy, cell death, and cancer
title_fullStr Autophagy, cell death, and cancer
title_full_unstemmed Autophagy, cell death, and cancer
title_short Autophagy, cell death, and cancer
title_sort autophagy, cell death, and cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905302/
https://www.ncbi.nlm.nih.gov/pubmed/27308466
http://dx.doi.org/10.4161/23723556.2014.985913
work_keys_str_mv AT linlin autophagycelldeathandcancer
AT baehreckeerich autophagycelldeathandcancer